Cargando…
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial
BACKGROUND: Vitamin D deficiency has been associated with multiple diseases, but the causal relevance and underlying processes are not fully understood. Elucidating the mechanisms of action of drug treatments in humans is challenging, but application of functional genomic approaches in randomized tr...
Autores principales: | Berlanga-Taylor, Antonio J., Plant, Katharine, Dahl, Andrew, Lau, Evelyn, Hill, Michael, Sims, David, Heger, Andreas, Emberson, Jonathan, Armitage, Jane, Clarke, Robert, Knight, Julian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013786/ https://www.ncbi.nlm.nih.gov/pubmed/29685792 http://dx.doi.org/10.1016/j.ebiom.2018.04.010 |
Ejemplares similares
-
An Integrated Approach to Defining Genetic and Environmental Determinants for Major Clinical Outcomes Involving Vitamin D
por: Berlanga-Taylor, Antonio J., et al.
Publicado: (2014) -
Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST‐D (Biochemical Efficacy and Safety Trial of Vitamin D)
por: Tomson, Joseph, et al.
Publicado: (2017) -
Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care
por: Hin, H., et al.
Publicado: (2016) -
Estimation of the optimum dose of vitamin D for disease prevention in older people: Rationale, design and baseline characteristics of the BEST-D trial
por: Clarke, Robert, et al.
Publicado: (2015) -
Genomic mapping of the MHC transactivator CIITA using an integrated ChIP-seq and genetical genomics approach
por: Wong, Daniel, et al.
Publicado: (2014)